GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genedrive PLC (FRA:D6M) » Definitions » Other Income (Expense)

Genedrive (FRA:D6M) Other Income (Expense) : €-2.23 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Genedrive Other Income (Expense)?

Genedrive's other income expense for the Genedrive's pretax income for the six months ended in Dec. 2024 was €0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was €-2.23 Mil.

Genedrive Other Income (Expense) Historical Data

The historical data trend for Genedrive's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genedrive Other Income (Expense) Chart

Genedrive Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.50 4.50 - -0.88 -2.23

Genedrive Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.88 - -2.23 -

Genedrive Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-2.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genedrive  (FRA:D6M) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Genedrive Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genedrive PLC (FRA:D6M) » Definitions » Other Income (Expense)
Comparable Companies
LSE:PRM LSE:GENI LSE:ABDX LSE:VRCI LSE:LLAI LSE:AGL TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT DGX LH XPAR:BIM ILMN
Traded in Other Exchanges
GDR:UK
Address
Grafton Street, The Incubator Building, Manchester, GBR, M13 9XX
Website
http://www.genedriveplc.com
Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom and also has its presence in Europe, United States of America and Rest of the World.

Genedrive Headlines

No Headlines